男性不育市场规模、分享和趋势分析乐鱼体育手机网站入口sis Report By Test (DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination), By Treatment, By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Test
1.1.2 Treatment
1.1.3 Regional Scope
1.1.4 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis (Model 1)
1.6.2 Volume price analysis (model 2)
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective - 1
1.8.2 Objective - 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Test
2.2.2 Treatment
2.2.3 Region
2.3 Competitive Insights
2.4 Male Infertility Market Outlook, 2021
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.2 Market Segmentation
3.3 Penetration & Growth Prospect Mapping
3.3.1 Penetration Analysis
3.3.2 Market driver analysis
3.3.2.1 High Adoption of Assisted Reproductive Technology (ART)
3.3.2.2 Increasing incidence of infertility
3.3.2.3 Acquisitions, mergers, and partnerships in the market
3.3.2.4 Technological advancements
3.3.3 Market restraint analysis
3.3.3.1 High cost of treatment
3.4 Male Infertility Market: Business Environment Analysis Tools
3.4.1 Porter’s Five Forces Analysis
3.4.2 PESTEL Analysis
3.5 Clinical Trial Analysis
Chapter 4 Male Infertility Market: Test Analysis
4.1 Male Infertility Test Market Share Analysis, 2021 & 2030
4.2 Male Infertility Test Market: Segment Dashboard:
4.3 Market Size & Forecasts and Trend Analyses, 2017 - 2030 for the Test Segment
4.3.1 DNA Fragmentation Technique
4.3.1.1 DNA fragmentation technique market, 2017 - 2030 (USD Million)
4.3.2 Oxidative Stress Analysis
4.3.2.1 Oxidative stress analysis market, 2017 - 2030 (USD Million)
4.3.3 Microscopic Examination
4.3.3.1 Microscopic Examination market, 2017 - 2030 (USD Million)
4.3.4 Sperm Agglutination
4.3.4.1 Sperm agglutination market, 2017 - 2030 (USD Million)
4.3.5 Computer Assisted Semen Analysis
4.3.5.1 Computer-assisted semen analysis market, 2017 - 2030 (USD Million)
4.3.6 Sperm Penetration Assay
4.3.6.1 Sperm penetration assay market, 2017 - 2030 (USD Million)
4.3.7 Others
4.3.7.1 Others market, 2017 - 2030 (USD Million)
Chapter 5 Male Infertility Market: Treatment Analysis
5.1 Male Infertility Treatment Market Share Analysis, 2021 & 2030
5.2 Male Infertility Treatment Market: Segment Dashboard:
5.3 Market Size & Forecasts and Trend Analyses, 2017 - 2030 for the Treatment Segment
5.3.1 ART & Varicocele Surgery
5.3.1.1 ART & varicocele surgery market, 2017 - 2030 (USD Million)
5.3.2 Medication
5.3.2.1 Medication market, 2017 - 2030 (USD Million)
Chapter 6 Male Infertility Market: Regional Analysis
6.1 Male Infertility Regional Market Share Analysis, 2021 & 2030
6.2 Male Infertility Regional Market: Segment Dashboard
6.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
6.4 SWOT Analysis, by Region
6.4.1 North America
6.4.2 Europe
6.4.3 Asia Pacific
6.4.4 Latin America
6.4.5 MEA
6.5分et Size, & Forecasts, and Trend Analysis, 2017 - 2030
6.5.1 North America
6.5.1.1 North America male infertility market, 2017 - 2030 (USD Million)
6.5.1.1.1美国
6.5.1.1.1.1 Regulatory & reimbursement scenario
6.5.1.1.1.2 U.S. male infertility market, 2017 - 2030 (USD Million)
6.5.1.1.2 Canada
6.5.1.1.2.1 Regulatory & reimbursement scenario
6.5.1.1.2.2 Canada male infertility market, 2017 - 2030 (USD Million)
6.5.2 Europe
6.5.2.1 Europe male infertility market, 2017 - 2030 (USD Million)
6.5.2.1.1 U.K.
6.5.2.1.1.1 Regulatory & reimbursement scenario
6.5.2.1.1.2 U.K. male infertility market, 2017 - 2030 (USD Million)
6.5.2.1.2 Germany
6.5.2.1.2.1 Regulatory & reimbursement scenario
6.5.2.1.2.2 Germany male infertility market, 2017 - 2030 (USD Million)
6.5.2.1.3 France
6.5.2.1.3.1 Regulatory & reimbursement scenario
6.5.2.1.3.2 France male infertility market, 2017 - 2030 (USD Million)
6.5.2.1.4 Italy
6.5.2.1.4.1 Regulatory & reimbursement scenario
6.5.2.1.4.2 Italy male infertility market, 2017 - 2030 (USD Million)
6.5.2.1.5 Spain
6.5.2.1.5.1 Regulatory & reimbursement scenario
6.5.2.1.5.2 Spain male infertility market, 2017 - 2030 (USD Million)
6.5.3 Asia Pacific
6.5.3.1 Asia Pacific male infertility market, 2017 - 2030 (USD Million)
6.5.3.1.1 Japan
6.5.3.1.1.1 Regulatory & reimbursement scenario
6.5.3.1.1.2 Japan male infertility market, 2017 - 2030 (USD Million)
6.5.3.1.2 China
6.5.3.1.2.1 Regulatory & reimbursement scenario
6.5.3.1.2.2 China male infertility market, 2017 - 2030 (USD Million)
6.5.3.1.3 India
6.5.3.1.3.1 Regulatory & reimbursement scenario
6.5.3.1.3.2 India male infertility market, 2017 - 2030 (USD Million)
6.5.3.1.4 Australia
6.5.3.1.4.1 Regulatory & reimbursement scenario
6.5.3.1.4.2 Australia male infertility market, 2017 - 2030 (USD Million)
6.5.3.1.5 South Korea
6.5.3.1.5.1 Regulatory & reimbursement scenario
6.5.3.1.5.2 South Korea male infertility market, 2017 - 2030 (USD Million)
6.5.4 Latin America
6.5.4.1 Latin America male infertility market, 2017 - 2030 (USD Million)
6.5.4.1.1 Brazil
6.5.4.1.1.1 Regulatory & reimbursement scenario
6.5.4.1.1.2 Brazil male infertility market, 2017 - 2030 (USD Million)
6.5.4.1.2 Mexico
6.5.4.1.2.1 Regulatory & reimbursement scenario
6.5.4.1.2.2 Mexico male infertility market, 2017 - 2030 (USD Million)
6.5.4.1.3 Argentina
6.5.4.1.3.1 Regulatory & reimbursement scenario
6.5.4.1.3.2 Argentina male infertility market, 2017 - 2030 (USD Million)
6.5.5 Middle East and Africa (MEA)
6.5.5.1 MEA male infertility market, 2017 - 2030 (USD Million)
6.5.5.1.1 South Africa
6.5.5.1.1.1 Regulatory & reimbursement scenario
6.5.5.1.1.2 South Africa male infertility market, 2017 - 2030 (USD Million)
6.5.5.1.2 Saudi Arabia
6.5.5.1.2.1 Regulatory & reimbursement scenario
6.5.5.1.2.2 Saudi Arabia male infertility market, 2017 - 2030 (USD Million)
6.5.5.1.3 UAE
6.5.5.1.3.1 Regulatory & reimbursement scenario
6.5.5.1.3.2 UAE male infertility market, 2017 - 2030 (USD Million)
Chapter 7 Competitive Analysis
7.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
7.2 Vendor Landscape
7.2.1 Strategy Mapping
7.2.2推出新产品
7.2.3 Merger and Acquisition
7.2.4 Product Approvals
7.3 Company Market Position Analysis (Geographic Presence, Product Portfolio, Strategic Initiatives)
7.4 Company Profiles
7.4.1 EMD Serono, Inc.
7.4.1.1 Company overview
7.4.1.2 Financial performance
7.4.1.3 Product benchmarking
7.4.1.4 Strategic initiatives
7.4.2 Endo International plc
7.4.2.1 Company overview
7.4.2.2 Financial performance
7.4.2.3 Product benchmarking
7.4.2.4 Strategic initiatives
7.4.2.5 SWOT analysis
7.4.3 Sanofi
7.4.3.1 Company overview
7.4.3.2 Financial performance
7.4.3.3 Product benchmarking
7.4.3.4 Strategic initiatives
7.4.3.5 SWOT Analysis
7.4.4 Bayer Group
7.4.4.1 Company overview
7.4.4.2 Financial performance
7.4.4.3 Product benchmarking
7.4.4.4 Strategic initiatives
7.4.4.5 SWOT analysis
7.4.5 SCSA Diagnostics
7.4.5.1 Company overview
7.4.5.2 Product benchmarking
7.4.6 Andrology Solutions
7.4.6.1 Company overview
7.4.6.2 Product benchmarking
7.4.7 Halotech DNA SL
7.4.7.1 Company overview
7.4.7.2 Product benchmarking
7.4.7.3 Strategic initiatives
7.4.8 Intas Pharmaceuticals Ltd.
7.4.8.1 Company overview
7.4.8.2 Financial performance
7.4.8.3 Product benchmarking
7.4.8.4 Strategic initiatives
7.4.8.5 SWOT analysis
7.4.9 Aytu BioScience, Inc.
7.4.9.1 Company overview
7.4.9.2 Financial performance
7.4.9.3 Product Benchmarking
7.4.9.4 Strategic initiatives
7.4.9.5 SWOT Analysis
7.4.10下级法官la Pharmaceuticals
7.4.10.1 Company overview
7.4.10.2 Product benchmarking
7.4.10.3 Strategic initiatives
7.4.11 Vitrolife
7.4.11.1 Company overview
7.4.11.2 Financial performance
7.4.11.3 Product benchmarking
7.4.11.4 Strategic initiatives
7.4.11.5 SWOT Analysis
Chapter 8 Recommendations

List of Tables

TABLE 1 List of secondary sources
TABLE 2 North America Male Infertility market, by country, 2017 - 2030 (USD Million)
TABLE 3 North America Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 4 North America Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 5 U.S. Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 6 U.S. Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 7 Canada Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 8 Canada Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 9 Europe Male Infertility market, by country, 2017 - 2030 (USD Million)
TABLE 10 Europe Male Infertility market, by test, 2017 - 2030 (USD Million)
表11欧洲男性不育市场treatment, 2017 - 2030 (USD Million)
TABLE 12 U.K. Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 13 U.K. Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 14 Germany Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 15 Germany Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 16 France Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 17 France Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 18 Italy Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 19 Italy Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 20 Spain Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 21 Spain Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 22 Asia Pacific Male Infertility market, by country, 2017 - 2030 (USD Million)
TABLE 23 Asia Pacific Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 24 Asia Pacific Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 25 Japan Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 26 Japan Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 27 China Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 28 China Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 29 India Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 30 India Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 31 Australia Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 32 Australia Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 33 South Korea Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 34 South Korea Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 35 Latin America Male Infertility market, by country, 2017 - 2030 (USD Million)
TABLE 36 Latin America Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 37 Latin America Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 38 Brazil Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 39 Brazil Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 40 Mexico Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 41 Mexico Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 42 Argentina Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 43 Argentina Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 44 MEA Male Infertility market, by country, 2017 - 2030 (USD Million)
TABLE 45 MEA Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 46 MEA Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 47 South Africa Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 48 South Africa Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 49 Saudi Arabia Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 50 Saudi Arabia Male Infertility market, by treatment, 2017 - 2030 (USD Million)
TABLE 51 UAE Male Infertility market, by test, 2017 - 2030 (USD Million)
TABLE 52 UAE Male Infertility market, by treatment, 2017 - 2030 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market formulation & validation
FIG. 8 Male infertility market outlook, 2021 (USD Million)
FIG. 9 Market trends & outlook
FIG. 10 Male infertility market segmentation
FIG. 11 Penetration & growth prospect mapping
FIG. 12 Market driver relevance analysis (Current & future impact)
FIG. 13 Market restraint relevance analysis (Current & future impact)
FIG. 14 Porter’s five forces analysis
FIG. 15 PESTEL analysis
FIG. 16 Male infertility test market share analysis, 2021 & 2030
FIG. 17 Male infertility test market: Segment dashboard
FIG. 18 DNA fragmentation technique market, 2017 - 2030 (USD Million)
FIG. 19 Oxidative stress analysis market, 2017 - 2030 (USD Million)
FIG. 20 Microscopic examination market, 2017 - 2030 (USD Million)
FIG. 21 Sperm agglutination market, 2017 - 2030 (USD Million)
FIG. 22 Computer assisted semen analysis market, 2017 - 2030 (USD Million)
FIG. 23 Sperm penetration assay market, 2017 - 2030 (USD Million)
FIG. 24 Others market, 2017 - 2030 (USD Million)
FIG. 25 Male infertility treatment market share analysis, 2021 & 2030
FIG. 26 Male infertility treatment market: Segment dashboard
FIG. 27 ART & varicocele surgery market, 2017 - 2030 (USD Million)
FIG. 28 Medication market, 2017 - 2030 (USD Million)
FIG. 29 Male infertility regional market share analysis, 2021 & 2030
FIG. 30 Male infertility regional market: Segment dashboard
FIG. 31 Regional market place: Key takeaways
FIG. 32 North America male infertility market, 2017 - 2030 (USD Million)
FIG. 33 U.S. male infertility market, 2017 - 2030 (USD Million)
FIG. 34 Canada male infertility market, 2017 - 2030 (USD Million)
FIG. 35 Europe male infertility market, 2017 - 2030 (USD Million)
FIG. 36 U.K. male infertility market, 2017 - 2030 (USD Million)
FIG. 37 Germany male infertility market, 2017 - 2030 (USD Million)
FIG. 38 France male infertility market, 2017 - 2030 (USD Million)
FIG. 39 Italy male infertility market, 2017 - 2030 (USD Million)
FIG. 40 Spain male infertility market, 2017 - 2030 (USD Million)
FIG. 41 Asia Pacific male infertility market, 2017 - 2030 (USD Million)
FIG. 42 Japan male infertility market, 2017 - 2030 (USD Million)
FIG. 43 China male infertility market, 2017 - 2030 (USD Million)
FIG. 44 India male infertility market, 2017 - 2030 (USD Million)
FIG. 45 Australia male infertility market, 2017 - 2030 (USD Million)
FIG. 46 South Korea male infertility market, 2017 - 2030 (USD Million)
FIG. 47 Latin America male infertility market, 2017 - 2030 (USD Million)
FIG. 48 Brazil male infertility market, 2017 - 2030 (USD Million)
FIG. 49 Mexico male infertility market, 2017 - 2030 (USD Million)
FIG. 50 Argentina male infertility market, 2017 - 2030 (USD Million)
FIG. 51 MEA male infertility market, 2017 - 2030 (USD Million)
FIG. 52 South Africa male infertility market, 2017 - 2030 (USD Million)
FIG. 53 Saudi Arabia male infertility market, 2017 - 2030 (USD Million)
FIG. 54 UAE male infertility market, 2017 - 2030 (USD Million)
FIG. 55 Recent development & impact analysis
FIG. 56 Company Categorization
FIG. 57 Company market position analysis